Rituximab may prove effective for treating membranous nephropathyAccording to recent findings appearing in the April 2009 print issue of the Clinical Journal of the American Society of Nephrology (CJASN), rituximab may be highly effective for treating a kidney disorder, membranous nephropathy.

Present treatments for this disorder are limited to steroids, chemotherapeutic agents, and calcineurin inhibitors and all of them have some considerable side effects.

Andrew Bomback, MD (University of North Carolina Kidney Center), and his colleagues, completed this study that highlighted the fact that rituximab dosing was able to achieve a 15-20 percent rate of complete remission and 35-40 percent of partial remission.

It is believed that this study on membranous nephropathy would provide a path-breaking treatment option.